Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6868-6874

  Huang, Huatao ^a   Colella, Stefano ^a   Kurrer, Michael ^b   Yonekawa, Yasuhiro ^c   Kleihues, Paul ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Departments of Pathology   (France)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MYC PROTEIN; OSTEONECTIN; PROTEIN KINASE; RIBOSOME PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; ARTICLE; ASTROCYTOMA; AUTORADIOGRAPHY; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 0034671669     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Diffuse astrocytoma
2. Low-grade diffuse astrocytomas
3. Gemistocytic astrocytomas: A reappraisal
4. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression
5. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
6. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas
7. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression
8. Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors
9. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
10. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype
11. Distribution of SPARC in normal and neoplastic human tissue
12. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
13. Platelet-derived growth factor: A general review with emphasis on astrocytomas
14. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma
15. Genetics of glioma progression and the definition of primary and secondary glioblastoma
16. Primary and secondary glioblastomas: From concept to clinical diagnosis
17. Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis
18. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis
19. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands
20. Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells
21. Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas
22. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes
23. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity human melanoma cells
24. Terms of attachment: SPARC and tumorigenesis
25. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer
26. Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas
27. SPARC: A potential diagnostic marker of invasive meningiomas
28. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas
29. Mechanisms of glioma invasion: Role of matrix metalloproteinases
30. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
31. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts
32. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
33. The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: Identification of multiple polyadenylation sites and a stromal pattern of expression
34. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences
35. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers
36. A public database for gene expression in human cancers
37. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth
38. Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells
39. The rat gene homologous to the human gene 9-27 is involved in the development of the mammary gland